These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 22435425)

  • 1. The roles of cells and cytokines in the pathogenesis of psoriasis.
    Coimbra S; Figueiredo A; Castro E; Rocha-Pereira P; Santos-Silva A
    Int J Dermatol; 2012 Apr; 51(4):389-95; quiz 395-8. PubMed ID: 22435425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical role of the interleukin-23/T-helper 17 cell axis in the pathogenesis of psoriasis.
    Nakajima K
    J Dermatol; 2012 Mar; 39(3):219-24. PubMed ID: 22352845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Th1, Th2, Th17 and regulatory T cell pattern in psoriatic patients: modulation of cytokines and gene targets induced by etanercept treatment and correlation with clinical response.
    Quaglino P; Bergallo M; Ponti R; Barberio E; Cicchelli S; Buffa E; Comessatti A; Costa C; Terlizzi ME; Astegiano S; Novelli M; Cavallo R; Bernengo MG
    Dermatology; 2011; 223(1):57-67. PubMed ID: 21865674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine network in psoriasis revisited.
    Michalak-Stoma A; Pietrzak A; Szepietowski JC; Zalewska-Janowska A; Paszkowski T; Chodorowska G
    Eur Cytokine Netw; 2011 Dec; 22(4):160-8. PubMed ID: 22236965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunopathogenesis and role of T cells in psoriasis.
    Ghoreschi K; Weigert C; Röcken M
    Clin Dermatol; 2007; 25(6):574-80. PubMed ID: 18021895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-17-producing CD8+ T lymphocytes from psoriasis skin plaques are cytotoxic effector cells that secrete Th17-related cytokines.
    Ortega C; Fernández-A S; Carrillo JM; Romero P; Molina IJ; Moreno JC; Santamaría M
    J Leukoc Biol; 2009 Aug; 86(2):435-43. PubMed ID: 19487306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-23 and interleukin-17: importance in pathogenesis and therapy of psoriasis.
    Mudigonda P; Mudigonda T; Feneran AN; Alamdari HS; Sandoval L; Feldman SR
    Dermatol Online J; 2012 Oct; 18(10):1. PubMed ID: 23122008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin 17A: toward a new understanding of psoriasis pathogenesis.
    Lynde CW; Poulin Y; Vender R; Bourcier M; Khalil S
    J Am Acad Dermatol; 2014 Jul; 71(1):141-50. PubMed ID: 24655820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monocyte-derived interferon-alpha primed dendritic cells in the pathogenesis of psoriasis: new pieces in the puzzle.
    Farkas A; Kemény L
    Int Immunopharmacol; 2012 Jun; 13(2):215-8. PubMed ID: 22522054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three decades of psoriasis research: where has it led us?
    Sabat R; Sterry W; Philipp S; Wolk K
    Clin Dermatol; 2007; 25(6):504-9. PubMed ID: 18021885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the Th17 pathway in psoriasis.
    Elloso MM; Gomez-Angelats M; Fourie AM
    J Leukoc Biol; 2012 Dec; 92(6):1187-97. PubMed ID: 22962689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The phosphodiesterase 4 inhibitor apremilast inhibits Th1 but promotes Th17 responses induced by 6-sulfo LacNAc (slan) dendritic cells.
    Oehrl S; Prakash H; Ebling A; Trenkler N; Wölbing P; Kunze A; Döbel T; Schmitz M; Enk A; Schäkel K
    J Dermatol Sci; 2017 Aug; 87(2):110-115. PubMed ID: 28499587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor necrosis factor alpha blockade exacerbates murine psoriasis-like disease by enhancing Th17 function and decreasing expansion of Treg cells.
    Ma HL; Napierata L; Stedman N; Benoit S; Collins M; Nickerson-Nutter C; Young DA
    Arthritis Rheum; 2010 Feb; 62(2):430-40. PubMed ID: 20112373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innate immunity in the pathogenesis of psoriasis.
    Sweeney CM; Tobin AM; Kirby B
    Arch Dermatol Res; 2011 Dec; 303(10):691-705. PubMed ID: 21863252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of psoriasis by continuous neutrophil infiltration into the epidermis.
    Katayama H
    Exp Dermatol; 2018 Oct; 27(10):1084-1091. PubMed ID: 30019426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psoriasis and other Th17-mediated skin diseases.
    Tokura Y; Mori T; Hino R
    J UOEH; 2010 Dec; 32(4):317-28. PubMed ID: 21226422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resident skin cells in psoriasis: a special look at the pathogenetic functions of keratinocytes.
    Albanesi C; De Pità O; Girolomoni G
    Clin Dermatol; 2007; 25(6):581-8. PubMed ID: 18021896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Th1, Th17, and Treg Responses are Differently Modulated by TNF-α Inhibitors and Methotrexate in Psoriasis Patients.
    Furiati SC; Catarino JS; Silva MV; Silva RF; Estevam RB; Teodoro RB; Pereira SL; Ataide M; Rodrigues V; Rodrigues DBR
    Sci Rep; 2019 May; 9(1):7526. PubMed ID: 31101850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From bench to bedside--translational research in psoriasis.
    Prinz JC
    J Eur Acad Dermatol Venereol; 2010 Oct; 24 Suppl 6():1-4. PubMed ID: 20831702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathophysiology of psoriasis: recent advances on IL-23 and Th17 cytokines.
    Fitch E; Harper E; Skorcheva I; Kurtz SE; Blauvelt A
    Curr Rheumatol Rep; 2007 Dec; 9(6):461-7. PubMed ID: 18177599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.